STAT3-mediated TLR2/4 pathway upregulation in an IFN-gamma-induced Chlamydia trachomatis persistent infection model.
暂无分享,去创建一个
Lijia Xiao | Yong Wang | P. Yu | Fuyan Wang | Chunjing Chen | Lingli Tang | Lin Lin
[1] T. Vogl,et al. IL-6 Amplifies TLR Mediated Cytokine and Chemokine Production: Implications for the Pathogenesis of Rheumatic Inflammatory Diseases , 2014, PloS one.
[2] D. Ojcius,et al. Chlamydia trachomatis infection increases the expression of inflammatory tumorigenic cytokines and chemokines as well as components of the Toll-like receptor and NF-κB pathways in human prostate epithelial cells. , 2014, Molecular and cellular probes.
[3] Yihong Yao,et al. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. , 2014, Pharmacology & therapeutics.
[4] B. Jenkins,et al. Tying the knot between cytokine and toll‐like receptor signaling in gastrointestinal tract cancers , 2013, Cancer science.
[5] H. Kita,et al. TLR3 activation evokes IL-6 secretion, autocrine regulation of Stat3 signaling and TLR2 expression in human bronchial epithelial cells , 2013, Journal of cell communication and signaling.
[6] A. Parker,et al. STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation. , 2012, Cancer cell.
[7] S. Petrini,et al. Amplification of the response to Toll-like receptor ligands by prolonged exposure to interleukin-6 in mice: implication for the pathogenesis of macrophage activation syndrome. , 2012, Arthritis and rheumatism.
[8] V. Vats,et al. Expression of TLR 2, TLR 4 and iNOS in Cervical Monocytes of Chlamydia trachomatis‐infected Women and Their Role in Host Immune Response , 2011, American journal of reproductive immunology.
[9] G. Stark,et al. The functions of signal transducers and activators of transcriptions 1 and 3 as cytokine-inducible proteins. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[10] J. Dayer,et al. Interleukin-6: from identification of the cytokine to development of targeted treatments. , 2010, Joint, bone, spine : revue du rhumatisme.
[11] C. Erridge. Endogenous ligands of TLR2 and TLR4: agonists or assistants? , 2010, Journal of leukocyte biology.
[12] R. Jha,et al. In infertile women, cells from Chlamydia trachomatis infected site release higher levels of interferon-gamma, interleukin-10 and tumor necrosis factor-alpha upon heat shock protein stimulation than fertile women , 2008, Reproductive biology and endocrinology : RB&E.
[13] C. Cuffini,et al. Susceptibility of Prostate Epithelial Cells to Chlamydia muridarum Infection and Their Role in Innate Immunity by Recruitment of Intracellular Toll-Like Receptors 4 and 2 and MyD88 to the Inclusion , 2006, Infection and Immunity.
[14] A. Visintin,et al. Localization of TLR2 and MyD88 to Chlamydia trachomatis Inclusions , 2006, Journal of Biological Chemistry.
[15] J. Whittimore,et al. Chlamydia trachomatis enters a viable but non‐cultivable (persistent) state within herpes simplex virus type 2 (HSV‐2) co‐infected host cells , 2006, Cellular microbiology.
[16] Shizuo Akira,et al. TLR signaling pathways. , 2004, Seminars in immunology.
[17] D. Virok,et al. Transcriptome analysis of chlamydial growth during IFN-γ-mediated persistence and reactivation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] H. Wagner,et al. Differential Contribution of Toll-Like Receptors 4 and 2 to the Cytokine Response to Salmonella enterica Serovar Typhimurium and Staphylococcus aureus in Mice , 2003, Infection and Immunity.
[19] T. Darville,et al. Differences in Innate Immune Responses (In Vitro) to HeLa Cells Infected with Nondisseminating Serovar E and Disseminating Serovar L2 of Chlamydia trachomatis , 2002, Infection and Immunity.
[20] R. Stephens. The cellular paradigm of chlamydial pathogenesis. , 2003, Trends in microbiology.